Resumo

GUTIERREZ SUAREZ, Jennifer Carolina; ALMONACID URREGO, Carmen Cecilia; HERNANDEZ ROJAS, Edith del Carmen  e  MENDIETA ZERON, Hugo. Prognostic value of biochemical markers in patients with COVID-19. Nova [online]. 2020, vol.18, n.spe35, pp.53-60.  Epub 15-Jan-2021. ISSN 1794-2470.  https://doi.org/10.22490/24629448.4186.

SARS-CoV-2 is a virus from the coronaviridae family, coronavirus (CoV) subfamily and genus β, it has become an imminent threat to all humanity as it is the causal agent of the COVID-19 pandemic, which led to On the one hand, the World Health Organization (WHO) declares a worldwide health emergency, and on the other, to institute strict control measures to prevent its spread by many governments. Regarding the pathophysiology presented in this entity, although lung lesions have been considered the main consequences of this infection, as knowledge about the virus progresses, cardiac, hepatic, and renal lesions have also been identified that enhance severity of the infection generating greater deterioration of the patients, their admission to the Intensive Care Units and a higher risk of mortality; Based on this, various investigations have aimed to determine those clinical and paraclinical findings that may be relevant to the prognosis of the patients. Therefore, this review addresses available literature on the main biochemical biomarkers reported for their association with cardiac, liver and kidney damage, which are more significant in evaluating the course, severity, management and prognosis of the infection and whose alteration ultimately leads to an increased risk of mortality in hospitalized patients presenting with COVID-19.

Palavras-chave : Diagnostic; COVID-19; Biomarkers; Screening; Biotransformation; Metabolism.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )